# Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

> **NCT00389103** · PHASE1 · WITHDRAWN · sponsor: **Sanofi Pasteur, a Sanofi Company**

## Conditions studied

- Smallpox
- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** MVA (smallpox vaccine)

## Key facts

- **NCT ID:** NCT00389103
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Senior management decision
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389103, "Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00389103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*